In this study, we found using microarray that the expression of CLC2, CLC3, CLCA1, CLCA4 and CFTR were down-regulated significantly in early CRC patients and this reduced expression of CLCA1 was confirmed by immunofluorescent staining of tissue from CRC patients (Fig. 1). This evidence concerns the gene CLCN2 and colorectal carcinoma.